SOTYKTU is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Deucravacitinib.
| Product ID | 0003-0895_ff4d7258-5068-4cdf-9692-8cae04c3198e | 
| NDC | 0003-0895 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | SOTYKTU | 
| Generic Name | Deucravacitinib | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2022-09-09 | 
| Marketing Category | NDA / | 
| Application Number | NDA214958 | 
| Labeler Name | E.R. Squibb & Sons, L.L.C. | 
| Substance Name | DEUCRAVACITINIB | 
| Active Ingredient Strength | 6 mg/1 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-09-09 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  SOTYKTU  97558218  not registered Live/Pending | Bristol-Myers Squibb Company 2022-08-22 | 
|  SOTYKTU  97287564  not registered Live/Pending | Bristol-Myers Squibb Company 2022-02-28 | 
|  SOTYKTU  90718747  not registered Live/Pending | Bristol-Myers Squibb Company 2021-05-18 |